ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,002 | -26.6% | 30,108 | -2.6% | 0.01% | -15.4% |
| Q2 2023 | $1,102,179 | +37.3% | 30,908 | -2.2% | 0.01% | +30.0% |
| Q1 2023 | $802,843 | -36.5% | 31,608 | +1.4% | 0.01% | -37.5% |
| Q4 2022 | $1,264,661 | +24.0% | 31,180 | +1.1% | 0.02% | +6.7% |
| Q3 2022 | $1,020,000 | -6.1% | 30,851 | 0.0% | 0.02% | -6.2% |
| Q2 2022 | $1,086,000 | -29.1% | 30,851 | -7.4% | 0.02% | 0.0% |
| Q1 2022 | $1,532,000 | -32.3% | 33,320 | -2.3% | 0.02% | -36.0% |
| Q4 2021 | $2,262,000 | +3.2% | 34,120 | -2.8% | 0.02% | 0.0% |
| Q3 2021 | $2,192,000 | -25.3% | 35,106 | -0.9% | 0.02% | -24.2% |
| Q2 2021 | $2,933,000 | +29.5% | 35,413 | +3.7% | 0.03% | +22.2% |
| Q1 2021 | $2,265,000 | -13.0% | 34,158 | +0.7% | 0.03% | -20.6% |
| Q4 2020 | $2,604,000 | +74.8% | 33,933 | -2.0% | 0.03% | +54.5% |
| Q3 2020 | $1,490,000 | -7.2% | 34,610 | -6.9% | 0.02% | -8.3% |
| Q2 2020 | $1,605,000 | +48.2% | 37,158 | -1.3% | 0.02% | +26.3% |
| Q1 2020 | $1,083,000 | -55.0% | 37,658 | -0.7% | 0.02% | -44.1% |
| Q4 2019 | $2,406,000 | +126.6% | 37,935 | +0.6% | 0.03% | +142.9% |
| Q3 2019 | $1,062,000 | +5489.5% | 37,700 | +5285.7% | 0.01% | – |
| Q2 2019 | $19,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |